In: Journal of Antimicrobial Chemotherapy, ///-
|
In: Journal of Antimicrobial Chemotherapy, 2017, vol. 72, no. 4, p. 1089-1093
|
In: Journal of Antimicrobial Chemotherapy, 2017, vol. 72, no. 2, p. 376-384
|
In: Journal of Antimicrobial Chemotherapy, ///-
|
In: Journal of Antimicrobial Chemotherapy, 2016, vol. 71, no. 1, p. 156-161
|
In: Journal of Antimicrobial Chemotherapy, 2016, vol. 71, no. 8, p. 2318-2320
|
In: Journal of Antimicrobial Chemotherapy, 2017, vol. 72, no. 11, p. 3070-3078
|
In: Journal of Antimicrobial Chemotherapy, 2018, vol. 73, no. 2, p. 385-391
|
In: Diagnostic Microbiology and Infectious Disease, 2021, vol. 99, no. 3, p. 115280
The NitroSpeed-Carba NP test was used to rapidly detect and discriminate between the different types of carbapenemases (classes A, B, and D) within 30 minutes among a collection of 202 Pseudomonas sp. strains (mostly Pseudomonas aeruginosa). A total of 99 carbapenemase–(including enzymes exhibiting weak carbapenemase activity such as several Guyana Extended-Spectrum (GES)-ß-lactamases) and...
|
In: International Journal of Antimicrobial Agents, 2020, vol. 56, no. 6, p. 106157
Background: Carbapenemase-producing Gram-negative bacteria cause infections that are difficult to treat and represent a rising threat to healthcare systems worldwide. This study analysed isolates of Escherichia coli (E. coli), a species associated with nosocomial-acquired and community-acquired infections, from hospitals in Germany and Switzerland exhibiting a slight decrease in...
|